In connection with the known antisecretory activity of the benzotriazepinone (1) and the pyridylurea (2), novel pyridotriazepinones (3 and 4) have been synthesized. They were prepared from aminopyridinecarboxylic acids via several steps, and their structures were confirmed by X-ray crystallographic analysis. Attempts to synthesize the positional isomer (24) resulted in formation of the pyridotriazine (25 or 26). Some of these compounds showed moderate antisecretory activity in rats.
Some antisecretory compounds have their origins in psychotropic agents." Among such compounds, 1,4-dihydro-4-methyl-5H-benzo-1,2,4-triazepin-5-one (1) is known to have antisecretory activity with diminished central nervous system (CNS) activity.2) On the other hand, a number of pyridine derivatives were recently reported to inhibit gastric acid secretion, as exemplified by the pyridylurea derivative (2) .3) In the course of our continuing studies on antisecretory agents, we were interested in the activities of 1,4-dihydro-4-methyl-5H-pyrido [2,3-f]-1,2,4-triazepin-5-one (3) and 1,4-dihydro-4-methyl-5H-pyrido [2,3-e] -1,2,4-triazepin-5-one (4) , which are pyrido analogues of 1. No reports have appeared on the synthesis and biological activity of pyridotriazepinones, in contrast with benzotriazepinone derivatives.4) We describe here the syntheses of the new pyridotriazepinones (3, 4) and the results of several attempts to synthesize the other positional isomer (24). Since structural assignment for benzotriazepinones has sometimes been erroneous and has been intensively discussed in recent papers,5) the structures of the pyrido analogues (3, 4) and related products in this study were confirmed by X-ray crystallographic analysis. The antisecretory activity of the resulting compounds determined in rats is also presented.
The pyrido [2, 34] On treatment with 1 molar equivalent of NaOH in Me0H, 7 gave a mixture of the monoester (10), the ring-fissioned product (11), and the triazepinone (3) in yields of 6, 4.3, and 13%, respectively. The spectral data and elemental analysis of 10 were compatible with the assigned structure and are given in the experimental section. The 1H-NMR spectrum of 11 showed, in addition to two OMe signals (6 4.06 and 4.10), the signal due to the NMe group in the secondary amide at 6 2.95 as a doublet, which collapsed to a singlet on addition of D20. In its IR spectrum, 11 showed strong carbonyl bands at 1675 and 1720 cm -1 assignable to amide and ester groups. Compound 11 was correctly analyzed for C11i,N,Q, and showed the molecular ion peak at m/e 266. On the basis of these data, we tentatively assigned the ringfissioned structure (11) to this compound. Susceptibility to cleavage of the C3-N4 bond of 1,2,4-triazepinones was also observed for the dihydro derivative (12), obtained by catalytic hydrogenation of 7. When heated in boiling EtOH for 7 h, 12 readily gave the ring-fissioned product (13) in 89% yield. Compound 13 showed spectroscopic data similar to those of 11 (see Experimental). The-pyrido [2,3-e] -1,2,4-triazepinone (4), a positional isomer of 3, was synthesized from 2-aminonicotinic acid (14a) (Chart 3). Treatment of 14a with methylhydrazine by the use of HOBt and DCC yielded the amide (15). Reaction of 15 with triethyl orthoformate (HC(OEt)3) in boiling EtOH gave the desired product (4) in 52% yield. Since the pyridopyrimidone (17) is also a possible product of this sequence of reactions,7 17 was synthesized independently. Heating of ethyl 2-aminonicotinate (14b) with methylhydrazine yielded the secondary amide (16), which is isomeric with 15. The 1H-NMR spectrum of 16 showed the NMe signal at 6 2.71 as a doublet, which collapsed to a singlet on addition of D2O. On the other hand, the NMe signal of 15 appeared at 6 3.25 as a singlet.8) Cyclization of 16 with (Fig. 2) . We next planned to prepare pyrido-1, 2,4-triazepinones (19a, b) having an amino group at C2 by the cyclodesulfurization9) of the thiosemicarbazide (18a, b). However, treatment of 18a, b10) with DCC in pyridine only yielded the 1, 3,4-oxadiazole (20a, b) (Chart 4) . Similar formation of oxadiazole derivatives was reported for the corresponding benzo analogues by Peet et al.") The structural assignments of 20a, b were based on the presence of signals due to a primary amino group in the 1H-NMR spectra and the characteristic MS fragmentation pattern. These spectral data are quite similar to those reported for 2-(2-aminophenyl)-1,3,4-oxadiazole derivatives.11) Synthesis of the 3-substituted pyrido-1,2,5-triazepinone (24) was also attempted (Chart 5). Condensation of 3-nitro-2-pyridylhydrazines (21a, b)12) with ethyl pyruvate or ethyl phenylglyoxylate gave the corresponding nitro-hydrazones (22a-d).13) Catalytic hydrogenation of the nitro-hydrazones (22a, b) afforded a mixture of the corresponding amino- hydrazones (23a, b) and pyrido [2,1-c] triazines (25a, b) instead of the desired triazepinone (24). Since the formation of 25a, b from 23a, b might be due to a tautomeric contribution of the hydrogen on the hydrazone group, catalytic hydrogenation of the corresponding N-methyl derivative (22c) was attempted. In this case, however, the aminal (26c) was obtained in 87% yield. Several attempts to convert 26c to 24 (R1 = R2 = Me) under acidic or alkaline conditions were unsuccessful. Similarly, catalytic hydrogenation of 22d gave 26d in 59% yield. Alternatively, 26d could be obtained by the reaction of 1-(3-amino-2-pyridyl)-lmethylhydrazine (27b)12) with ethyl phenylglyoxylate in 68% yield. As an alternative route to 24 (R1 H, R2 Ph), condensation of the aminohydrazine (27a)12) with ethyl phenylglyoxylate was also attempted. The major product (51 %) in this reaction, however, was the pyrido [2,3-b] pyrazine (28), compounds 23b and 25b being also isolated in low yields. The presence of the primary amino group in 28 was demonstrated by its conversion to the isopropylidene derivative (29) and the N-acetate (30). The structures of the pyridotriazines (25a and 26d) and the pyridopyrazine (28) were unequivocally confirmed by X-ray crystallographic analysis, and perspective drawings are shown in Figs. 3, 4, and 5, respectively.
Pharmacology
The pyridotriazepinone derivatives and related compounds obtained in this study were tested for antisecretory activity in rats after intraperitoneal (i.p.) administration by the method reported previously.14) The results are summarized in Table I together with comparative data for the benzotriazepinone (1). The antisecretory activity of the pyridotriazepinones (3 and 4) is of the same order as that of the benzo analogue (1).
Experimental
All melting points are uncorrected. IR spectra were recorded in Nujol mulls on a Hitachi IR-215 spectrometer. 50.25; H, 4.74; N, 36.63. Found: C, 50.27; H, 4.75; N, 3, Ethyl 2-(3-Nitro-2-pyridylhydrazono)phenylacetate (22b) This compound was prepared by the reaction of 21a and ethyl phenylglyoxylate in the same manner as described above to give 22b (68%), mp 135-137 C (from EtOH). IR (Nujol): 3220, 1725 , 1705 , 1680 , 1590 H, 4.49; N, 17.83. Found: C, 57.03; H, 4.42; N, 17.80. Ethyl 2-[Methyl(3-nitro-2-pyridyl) hydrazono]propionate (22c) A mixture of 211)12) (3.37 g, 20 mmol), ethyl pyruvate (2.37 g, 20 mmol), H3PO4 (85%, 2 ml), and EtOH (30 ml) was stirred at room temperature for 15 h and then poured onto ice-sticks. The mixture was extracted with CHCl3. The CHCl3 extracts were washed with aq. NaCl and dried over Na2SO4. The solvent was evaporated, and the residue was recrystallized from aq. EtOH to give 22c (4.14g, 78%) Ethyl 2-(3-Amino-2-pyridylhydrazono)propionate (23a) and 9-Amino-3-methyl-4H-pyrido[2,1-c]-1,2,4-triazin-4-one (25a)-Compound 22a (1.88 g, 7.45 mmol) was hydrogenated in EtOH (50 ml) in the presence of 10% Pd-C (0.15 g) under 2.5 atm pressure. After 50 min, Pd-C and the solvent were removed. The residue was purified by chromatography (SiO2, CHCl3 : MeOH =100 ; 1) to yield 23a (0.312 g, 19%) and 25a (0.304 g, 23%).
Compound 26d was also prepared as follows. Ethyl phenylglyoxylate (1.53 g, 8.59 mmol) and AcOH (0.3 ml) were added to a cold solution of 1-(3-amino-2-pyridyl)-1-methylhydrazine (27b, 1.18 g, 8.54 mmol) in EtOH (15 ml). The mixture was stirred at room temperature for 4d under an argon atmosphere, then the solvent was removed. The residue was dissolved in iso-Pr2O, treated with charcoal, and concentrated to give 26d (1.73g, 68%), which has physical data identical with those described above. 4-Isopropylidenamino-2-phenylpyrido [2,3-b] pyrazin-3(4H)-one (29) A mixture of 28 (0.1 g, 0.42 mmol), Me,CO (5 ml), and AcOH (0.5 ml) was heated for 2 h under reflux. After cooling, the mixture was concentrated, and the residue was recrystallized from Me2CO--hexane to give 29 (0.07 g, 60%) as pale yellow needles, mp 151-152 C. IR (Nujol): 1650, 1580 cm . MS m/e: 278 (M +), 235. Anal. Calcd for C16H14N4O: C, 69.05; H, 5.07; N, 20.13. Found: C, 68.70; H, 4.98; N, pyrazin-3(4H)-one (30) Compound 28 (0.784 g, 3.29 mmol) was dissolved in Ac2O (30 ml), and the mixture was stirred at room temperature overnight . Ac2O was evaporated, and the residue was recrystallized from a mixture of AcOEt and hexane to yield 30 (0.732 g, 79%), mp 176-178 C. IR (Nujol): 3250, 1690, 1645 cm 1. MS m/e: 280 (M ), 238. Anal. Calcd for C15H12N4O2: C, 64.27; H, 4.32; N, 19.99. Found: C, 64.20; H, 4.31: N, 19 .77.
X-Ray Crystallographic Analysis-The structures of compounds 3, 4, 25a, 26d and 28 were solved by the direct method using MULTAN and refined by the block-diagonal least-squares method. The crystal data are summarized in Table II. 
